Patents Assigned to Université de Montréal
  • Patent number: 11500224
    Abstract: A method for determining an optical system intended to equip a person on the basis of the adaptability of the person to a visual and/or proprioceptive modification of his environment, the method.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: November 15, 2022
    Assignees: Essilor International, Universite de Montreal
    Inventors: Guillaume Giraudet, Jocelyn Faubert, Rafael Doti, Eduardo Lugo
  • Patent number: 11493782
    Abstract: There is described a medical device for management of the axial length growth of an eye of a subject. The device comprises a central region having a first power, a transition region surrounding the central region, and a peripheral region surrounding the transition region and having a second power. The transition region has a width at most equal to 1.5 mm. The second power is chosen based on the first power to achieve a target net power, the target net power being the addition of the first power and the second power. The surface area of the central and peripheral regions is chosen as a function of the surface area of the pupil of the eye. Furthermore, the curve of power within the transition region is steep between the first power and the second power so that the transition region generates no optically usable power.
    Type: Grant
    Filed: November 23, 2018
    Date of Patent: November 8, 2022
    Assignee: Université de Montréal et al.
    Inventors: Patrick Simard, Jean Blanchard, Langis Michaud, Remy Marcotte-Collard
  • Patent number: 11479530
    Abstract: Small molecules comprised of azacyclic constrained sphingolipid-like compounds and methods of their synthesis are provided. Formulations and medicaments are also provided that are directed to the treatment of disease, such as, for example, neoplasms, cancers, and other diseases. Therapeutics are also provided containing a therapeutically effective dose of one or more small molecule compounds, present either as pharmaceutically effective salt or in pure form, including, but not limited to, formulations for oral, intravenous, or intramuscular administration.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: October 25, 2022
    Assignees: The Regents of the University of California, The Université de Montréal
    Inventors: Aimee L. Edinger, Stephen Hanessian
  • Publication number: 20220284303
    Abstract: A system simulating a decisional process in a mammal brain about characteristics of motions related to body gestures of a visually observed body through a simulated visual path is provided. The system includes an interface toward simulated neuronal structures, the interface at least converting luminous information of the observed body to an optic flow data stream conveying information related to the visually observed body and that can be processed in the simulated neuronal structures, the system being a feed-forward system and comprising hierarchically from the visual observation to the decision: the simulated visual path and its interface, a simulated local motion direction detection neuronal structure for the detection of motion directions with receptive fields, a simulated opponent motions detection neuronal structure, a simulated complex patterns detection neuronal structure, and a simulated motion pattern detection neuronal structure.
    Type: Application
    Filed: August 3, 2020
    Publication date: September 8, 2022
    Applicants: UNIVERSITE DE MONTREAL, Essilor International
    Inventors: Jocelyn FAUBERT, Khashayar MISAGHIAN, Eduardo LUGO, Delphine TRANVOUEZ-BERNARDIN
  • Publication number: 20220266017
    Abstract: A method for modulating a movement of a body part comprising: acquiring movement event data relating to the body part during a movement event, the movement event data including: a movement event parameter requiring modulation, a trigger value representative of a first time point in the movement event, and a target value representative of desired movement at a second, later, time point in the movement event; acquiring in real-time current movement data associated with a current movement event of the body part, the current movement data including current values of the movement event parameter; analyzing the current movement data to determine presence of the trigger value in the current movement event; and in response to identification of the trigger value in the current movement data, causing a brain stimulation assembly to apply a predetermined modulation signal to a brain motor region of the subject to cause the modulation of the body part towards the target value at the second time point in the current movem
    Type: Application
    Filed: July 30, 2020
    Publication date: August 25, 2022
    Applicant: UNIVERSITÉ DE MONTRÉAL
    Inventors: Marco Bonizzato, Marina Martinez
  • Publication number: 20220263114
    Abstract: The invention concerns a solid polymer electrolyte comprising a polymer matrix comprising at least one ionic salt, the polymer matrix comprising at least one polyalkene carbonate, at least one second polymer different from the polyalkene carbonate polymer, and at least one alkene carbonate coming from the decomposition of the polyalkene carbonate. The present invention also concerns a method for preparing the solid polymer electrolyte and a battery comprising the solid polymer electrolyte.
    Type: Application
    Filed: July 17, 2020
    Publication date: August 18, 2022
    Applicants: TotalEnergies SE, UNIVERSITE DE MONTREAL
    Inventors: David AYMÉ-PERROT, Mickaël DOLLÉ, David LEPAGE, Arnaud PRÉBÉ
  • Publication number: 20220246922
    Abstract: The present invention relates to a composite electrode for a device storing electrical energy wherein said electrode comprises an electrode body and an electrode shell, wherein said body comprises at least one water-soluble polymer and wherein at least a part of said shell comprises a shell comprising at least one organic or organometallic material. The present invention also relates to a device storing electrical energy comprising said composite electrode and a process for preparing said composite electrode.
    Type: Application
    Filed: June 3, 2020
    Publication date: August 4, 2022
    Applicants: TotalEnergies SE, UNIVERSITE DE MONTREAL
    Inventors: David AYME-PERROT, Jacopo PROFILI, Luc STAFFORD, Steeve ROUSSELOT, Mickaël DOLLE
  • Patent number: 11348572
    Abstract: A speech recognition method includes obtaining an acoustic sequence divided into a plurality of frames, and determining pronunciations in the acoustic sequence by predicting a duration of a same pronunciation in the acoustic sequence and skipping a pronunciation prediction for a frame corresponding to the duration.
    Type: Grant
    Filed: July 18, 2018
    Date of Patent: May 31, 2022
    Assignees: Samsung Electronics Co., Ltd., UNIVERSITE DE MONTREAL
    Inventors: Inchul Song, Junyoung Chung, Taesup Kim, Sanghyun Yoo
  • Publication number: 20220121040
    Abstract: A method for determining a design of a progressive lens intended to be worn by a future wearer, the progressive lens comprising a front surface and a back surface, at least one of the front surface and the back surface comprising a progression profile on its general spherical shape, said at least one progression profile defining a meridian line extending from a distance-vision point to a near-vision point, said meridian line comprising a vertical portion passing through the distance-vision point and an inclined portion passing through the near-vision point, the vertical portion and the inclined portion forming an angle between them, the method including obtaining first data representative of a first measurement of a first postural instability of the future wearer when seeing a visual pattern moving along an mediolateral direction, and determining a reparation between the first progression profile and the second progression profile based on the first data.
    Type: Application
    Filed: November 27, 2019
    Publication date: April 21, 2022
    Applicants: Essilor International, UNIVERSITE DE MONTREAL
    Inventors: Delphine TRANVOUEZ-BERNARDIN, Jocelyn FAUBERT, Guillaume GIRAUDET
  • Publication number: 20220026741
    Abstract: A method for determining a design of a progressive lens intended to be worn by a future wearer, the progressive lens comprising a front surface and a back surface, at least one of the front surface and the back surface comprising a progression profile on its general spherical shape, said at least one progression profile defining a meridian line extending from a distance-vision point to a near-vision point, said meridian line comprising a vertical portion passing through the distance-vision point and an inclined portion passing through the near-vision point, the vertical portion and the inclined portion forming an angle between them, the method comprising obtaining first data representative of a first measurement of a first postural instability of the future wearer when seeing at a visual pattern moving along an anterior-posterior direction, and determining the angle of the inclined portion based on the first data.
    Type: Application
    Filed: November 27, 2019
    Publication date: January 27, 2022
    Applicants: Essilor International, UNIVERSITE DE MONTREAL
    Inventors: Delphine TRANVOUEZ-BERNARDIN, Jocelyn FAUBERT, Guillaume GIRAUDET
  • Publication number: 20220011596
    Abstract: A system and method for determining an adapted ophthalmic device for a wearer, the method including acquiring a set of parameters values relating to the wearer, determining at least a task to be performed by the wearer involving visual exploration, using a computing system, determining a value of a criterion assessing an efficiency of the wearer's visual exploration strategy for the task, and determining an optical design of an ophthalmic device to be worn by a wearer according to the determined value of the criterion.
    Type: Application
    Filed: October 9, 2019
    Publication date: January 13, 2022
    Applicants: Essilor International, UNIVERSITE DE MONTREAL
    Inventors: Delphine BERNARDIN, Jocelyn FAUBERT, Romain CHAUMILLON, Eduardo LUGO, Sergio MEJIA ROMERO
  • Publication number: 20210322509
    Abstract: A method for preventing or reducing the risk of perinatal or neonatal morbidity and mortality caused by antenatal inflammation in humans is described. This method is based on the administration of a compound of formula I or a pharmaceutically acceptable salt thereof: to an expectant human mother suffering from antenatal fetal inflammation. The method prevents or reduces the risk of organ damages, including brain, lung and intestinal damages, and sequelae therefrom, in the neonates, as well as the risk of neonatal death.
    Type: Application
    Filed: June 30, 2021
    Publication date: October 21, 2021
    Applicants: CHU SAINTE-JUSTINE, UNIVERSITÉ DE MONTRÉAL, THE UNIVERSITY OF ADELAIDE
    Inventors: Sylvain CHEMTOB, Christiane QUINIOU, Sarah Anne ROBERTSON, Mathieu NADEAU-VALLÉE, William D. LUBELL, David OLSON, Peck Yin CHIN, Sylvie GIRARD, Doan-Ngoc DUC
  • Publication number: 20210261504
    Abstract: Small molecules comprised of azacyclic constrained sphingolipid-like compounds and methods of their synthesis are provided. Formulations and medicaments are also provided that are directed to the treatment of disease, such as, for example, neoplasms, cancers, and other diseases. Therapeutics are also provided containing a therapeutically effective dose of one or more small molecule compounds, present either as pharmaceutically effective salt or in pure form, including, but not limited to, formulations for oral, intravenous, or intramuscular administration.
    Type: Application
    Filed: March 8, 2021
    Publication date: August 26, 2021
    Applicants: The Regents of the University of California, The Université de Montréal
    Inventors: Aimee L. Edinger, Stephen Hanessian
  • Publication number: 20210261583
    Abstract: Small molecules compounds and methods of their synthesis are provided. Formulations and medicaments are also provided that are directed to the treatment of disease, such as, for example, neoplasms, cancers, and other diseases. Therapeutics are also provided containing a therapeutically effective dose of one or more small molecule compounds, present either as pharmaceutically effective salt or in pure form, including, but not limited to, formulations for oral, intravenous, or intramuscular administration.
    Type: Application
    Filed: June 14, 2019
    Publication date: August 26, 2021
    Applicants: The Regents of the University of California, Universite de Montreal
    Inventors: Aimee Edinger, Stephen Hanessian
  • Patent number: 11072616
    Abstract: There is described herein antagonists of ?4?7 integrin, and more particularly to cyclic peptide antagonists. Accordingly, there is described herein a compound of formula (I) wherein R1, R2, R3, R4, R5, R6, R7 and R8 are various substituents; stereocentres 1*, 2* and 3* are each independently selected from R and S; n is 1, 2, 3, or 4 and where n is 2-4, Z is an amino terminus of an amino acid; —C?O— adjacent L is the carboxy terminus of an amino acid; and L along with Z and —C?O— is a peptide.
    Type: Grant
    Filed: November 14, 2016
    Date of Patent: July 27, 2021
    Assignees: Universite de Montreal, Zealand Pharma A/S
    Inventors: Manuel Perez Vazquez, M. Monzur Morshed, Jennifer L. Hickey, Adam Paul Kafal, James Gillard, Narendra Patel, Sai Kumar Chakka, Andrew L. Roughton, Marc-André Poupart, Gaoqiang Yang
  • Patent number: 11046695
    Abstract: There is described herein use of a compound of formula (I) below to make cyclic peptides.
    Type: Grant
    Filed: November 14, 2016
    Date of Patent: June 29, 2021
    Assignees: Zealand Pharma A/S, Universite de Montreal
    Inventors: Manuel Perez Vazquez, M. Monzur Morshed, Jennifer L. Hickey, Marc-André Poupart, Gaoqiang Yang, James Gillard, Adam Paul Kafal, Andrew L. Roughton
  • Patent number: 10954194
    Abstract: The invention relates to a method of treating a subject who has cancer or a non-malignant tumor, the method comprising administering a therapeutically effective amount of a 18-20 member bi-polycyclic compound to the subject.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: March 23, 2021
    Assignees: Haro Pharmaceuticals Inc., The Royal Institution for the Advancement of Learning/ McGill University, Universite De Montreal
    Inventors: David Bettoun, Eduardo Martinez, James Gleason, Sylvie Mader, Shuo Xing
  • Patent number: 10877036
    Abstract: Resonance energy transfer (RET)- or protein-fragment complement assay (PCA)-based biosensors useful for assessing the activity of G-proteins are described. These biosensors are based on the competition between the G? subunit and a G?? interacting protein (?? IP) for the binding to the G?? dimer. These biosensors comprises (1) a ?? IP and (2) a G? or G? protein; a GPCR; or a plasma membrane targeting domain, fused to suitable RET or PCA tags. Methods using such biosensors for different applications, including the identification of agents that modulates G-protein activity or for the characterization of GPCR signaling/regulation, such as G-protein preferences and activation profiles of GPCRs, are also described.
    Type: Grant
    Filed: October 14, 2015
    Date of Patent: December 29, 2020
    Assignee: UNIVERSITÉ DE MONTRÉAL
    Inventors: Michel Bouvier, Christian Le Gouill, Mireille Hogue, Viktoriya Lukasheva
  • Publication number: 20200348536
    Abstract: A method for determining an optical system intended to equip a person on the basis of the adaptability of the person to a visual and/or proprioceptive modification of his environment, the method.
    Type: Application
    Filed: August 30, 2018
    Publication date: November 5, 2020
    Applicants: Essilor International, Universite de Montreal
    Inventors: Guillaume GIRAUDET, Jocelyn FAUBERT, Rafael DOTI, Eduardo LUGO
  • Patent number: 10822343
    Abstract: The present invention provides thiazole compounds of Formula I wherein W, Y, R0, R2, R4, R5, R6, R7, X1, X2, X3 and X4 are as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt, prodrug ester or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: November 3, 2020
    Assignees: Bristol-Myers Squibb Company, Université de Montréal
    Inventors: Jacques Banville, Roger Remillard, Edward H. Ruediger, Daniel H. Deon, Marc Gagnon, Laurence Dube, Julia Guy, Eldon Scott Priestley, Shoshana L. Posy, Brad D. Maxwell, Pancras C. Wong, R. Michael Lawrence, Michael M. Miller